Taken together, in HIV-CRC, reduced SERPINA1 may promote colorectal carcinogenesis and worsen prognosis through both enhanced HIV-induced inflammation and diminished host immunomodulation. This evidence concerns the gene SERPINA1 and colorectal carcinoma.